Welcome to our dedicated page for Ontrak news (Ticker: OTRK), a resource for investors and traders seeking the latest updates and insights on Ontrak stock.
Ontrak, Inc. (OTRK), also referred to as Ontrak Health, has generated a stream of news centered on its role as a value-based, AI-powered behavioral healthcare company and, later, on significant financing and corporate developments. Company press releases describe how Ontrak uses a proprietary Advanced Engagement System, AI, and predictive analytics to identify and engage vulnerable members of the behavioral health population, including individuals with anxiety, depression, substance use disorder, and chronic disease. News items frequently discuss its WholeHealth+, Engage, and Quality solutions, which are aimed at improving clinical outcomes and reducing total cost of care for health plans and other payors.
Visitors to the OTRK news page can review announcements about partnerships with health plans and health systems, such as agreements with Sentara Health Plans and Intermountain Health, as well as Medicaid provider designations obtained through an affiliated practice association in two states. These stories outline how Ontrak’s programs are deployed across Medicare Advantage, Medicaid, Commercial, and Marketplace populations, and how the company positions itself as a technology-enabled behavioral health partner.
The news flow also includes financial results releases, highlighting revenue trends, operating losses, and non-GAAP metrics, along with details of public offerings, financing commitments from Acuitas Capital LLC, and amendments to the company’s Keep Well Agreement. Later disclosures and filings referenced in press releases and SEC documents describe challenges such as customer concentration, the loss of a major prospect, and the company’s efforts to secure additional capital.
For investors and researchers, the OTRK news page provides a chronological view of how Ontrak presented its mission, solutions, customer relationships, and financial condition over time. It also offers context for key turning points, including the board’s decision to cease operations and subsequent Nasdaq delisting actions documented in SEC filings. Reviewing this news archive alongside regulatory filings can help users understand both the company’s behavioral health strategy and the risks that emerged in its business model.
Ontrak, Inc. (NASDAQ: OTRK) announced it will release its financial results for Q2 2022 on August 9, 2022, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss these results. As a leading AI and telehealth-enabled healthcare provider, Ontrak focuses on improving behavioral health outcomes for vulnerable populations through personalized care pathways and predictive analytics.
Ontrak, Inc. (NASDAQ: OTRK) has appointed Dr. Judith Feld as the new Chief Medical Officer, succeeding Dr. Robert Accordino, who leaves to focus on his private practice. Dr. Feld, who joined the company in 2019, has played a key role in developing Ontrak's clinical model aimed at engaging hard-to-reach health plan members. With over 30 years of experience and multiple accolades, she aims to enhance the health outcomes of members and improve services for health plan customers. The transition is seen as a positive step for Ontrak as it emphasizes internal talent and continuity in leadership.
Ontrak, Inc. (NASDAQ: OTRK) announced the resignation of CEO Jonathan Mayhew effective August 12, 2022, due to family health reasons. Founder Terren Peizer will assume the CEO role, focusing on strategic direction and capital initiatives. The company promoted several executives, including Brandon LaVerne to Co-President and COO, and Mary Lou Osborne to Co-President and Chief Commercial Officer. Historical revenue growth includes $2.7 million in 2015 to $84.1 million in 2021. Peizer's investment arm remains the largest shareholder.
Ontrak, Inc. (NASDAQ: OTRK), a leader in AI-powered telehealth, will participate in the Lytham Partners Summer 2022 Investor Conference. The presentation will be accessible from June 21, 2022, at 9:00 a.m. Eastern Time, via the company's website. Ontrak's mission focuses on enhancing healthcare for vulnerable populations facing mental health issues, including anxiety and substance use disorders. Their robust platform combines AI and personalized care pathways to improve member health and optimize healthcare utilization.
Ontrak Health (NASDAQ: OTRK) and Eleos Health announce a partnership to integrate their AI platforms, aiming to enhance member care in behavioral health. This collaboration will reduce administrative tasks and improve insights into treatment sessions. Eleos' voice-to-insights technology will streamline documentation, cutting completion time by up to 40%. This integration is expected to provide Ontrak's care teams with better visibility into patient needs and treatment effectiveness, ultimately supporting its mission to improve clinical outcomes for vulnerable populations.
Ontrak, Inc. (OTRK) reported Q1 2022 revenue of $5.3 million, an 82% decline year-over-year. The operating loss widened to $(13.1 million), compared to $(2.9 million) in Q1 2021. Adjusted EBITDA also fell to $(9.2 million) from $1.9 million year-over-year. The company highlighted a sales pipeline and plans to borrow up to $25 million from Acuitas Capital. Total enrolled members reached 2,867. Ontrak anticipates revenue for the full year 2022 between $25 million and $30 million.
Ontrak, Inc. (NASDAQ: OTRK) will announce its first-quarter 2022 financial results on May 11, 2022, after market close. Management will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss these results. Investors can access the call at +1 (833) 519-1269 for U.S. participants or (914) 800-3841 for international participants, referencing conference ID #5078624. A live and archived webcast will also be available on their website.
Ontrak, Inc. (NASDAQ: OTRK) reported Q4 2021 revenue of $10.3 million, a 65% decrease year-over-year, with a net loss of $(20.1 million). For the full year, revenue rose 2% to $84.1 million, but the operating loss widened to $(28.0 million). Key achievements include a three-year contract renewal with a major employer covering 39 countries, and a successful ATM offering raising $10.8 million. The company anticipates 2022 revenue between $25 - $30 million.
Ontrak, Inc. (NASDAQ: OTRK) announced its participation in the Cowen 42nd Annual Health Care Conference scheduled for March 9, 2022, at 1:30 p.m. Eastern Time. The company's management will host a fireside chat, and interested parties can access a live and archived webcast on their website's Investors section.
Ontrak focuses on utilizing AI and telehealth to improve healthcare for vulnerable behavioral health populations, offering personalized care and treatment pathways to those facing significant barriers in accessing care.
Ontrak, Inc. (NASDAQ: OTRK) will release its fourth quarter 2021 financial results on March 8, 2022, after market close. The company will host a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results. Ontrak focuses on leveraging AI and telehealth to improve healthcare for vulnerable populations facing behavioral health issues. The company aims to provide effective care pathways that address significant barriers in healthcare access.